好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Does Entrustment Match Performance? A Multi-institutional Simulation Study to Evaluate Validity of Entrustable Professional Activity-based Assessment for Neurocritical Care Advanced Practice Providers
好色先生, Research, and Methodology
S28 - Novel Approaches to Teaching, Assessment, and Beyond in Neurology 好色先生 (3:30 PM-3:42 PM)
001

APPs are key contributors to NCC teams. Six core and 47 nested entrustable professional activities (EPAs) for NCC APP training have been developed. These could be leveraged for EPA-based assessment, however, are not supported by validity evidence in this context.

To assess the relationship between checklist-based performance in simulated neurologic emergencies and supervisor- and self-assessed entrustment among neurocritical care (NCC) advanced practice providers (APPs).

Two simulation scenarios were created to assess performance related to six core and 15 nested-EPAs. The simulations’ critical action checklists were iteratively developed based upon guideline recommendations and consensus opinion from five collaborating institutions. Prior to participation, NCC APPs self-assessed their entrustment on the core and nested EPAs (the “EPA Assessment Tool”). APP supervisors completed the same assessment. After completing a rater training exercise, study staff completed the critical action checklists for each participant.

22 NCC APPs from 4 institutions participated in the study. There was a moderate positive association between physician supervisor assessed entrustment and performance on the critical action checklist (r= 0.47). There was a very strong positive association between physician supervisor assessed entrustment and participant NCC experience (r= 0.84). There was fair agreement in 393 physician and self-assessed EPAs (kw= 0.39). Overall entrustment was similar when assessed by physician supervisors (4.13 +/- 0.72 [5-point entrustment scale mean +/- standard deviation]) and participants (4.11 +/- 0.60, p= 0.83). For the subset of participants who were additionally assessed by an APP supervisor, overall entrustment was also similar between self- and supervisor-assessment (4.04+/-0.59 vs 4.20+/-0.73, p= 0.39).

There was moderate correlation between physician supervisor EPA-assessment and performance in the simulation. Physician supervisor assessments agreed fairly well with APP self-assessments. These results provide validity evidence for EPA-based assessment of NCC APPs. EPA self-assessment may be a reasonable strategy for identifying strengths and learning gaps in NCC APPs.
Authors/Disclosures
Daniel S. Harrison, MD (Boston Medical Center)
PRESENTER
Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scientia Imaging. Dr. Harrison has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Glass Health. Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Azurity.
Christa O'hana S. Nobleza, MD Dr. Nobleza has nothing to disclose.
Matthew B. Bevers, MD, PhD (Brigham and Women's Hospital) Dr. Bevers has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO. An immediate family member of Dr. Bevers has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for multiple law firms. Dr. Bevers has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for multiple law firms. The institution of Dr. Bevers has received research support from NINDS. The institution of an immediate family member of Dr. Bevers has received research support from AHRQ. The institution of an immediate family member of Dr. Bevers has received research support from NIH/Kowa Industries. The institution of an immediate family member of Dr. Bevers has received research support from NIDA.
Sahar Zafar, MD Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Zafar has received research support from NIH. Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker for a lecture with Marinus.
Ariel Nowicki Ms. Nowicki has nothing to disclose.
Elizabeth Woods (Massachusetts General Hospital) No disclosure on file
Kelly Peronti No disclosure on file
Erica Perets No disclosure on file
Erika Sigman, MD Dr. Sigman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
Rashid A. Ahmed, MD (Upstate University Hospital) Dr. Ahmed has nothing to disclose.
Casey S. Albin, MD (Emory Healthcare) Dr. Albin has received personal compensation in the range of $0-$499 for serving as a Consultant for Azurity Pharmaceutical. Dr. Albin has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum: Life Long Learning in Neurology. Dr. Albin has received research support from 好色先生. Dr. Albin has received publishing royalties from a publication relating to health care.